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Acute Fatty Liver of Pregnancy (AFLP) is a rare and 
fatal condition for both the mother and the unborn 
offspring accompanied by severe maternal liver 
dysfunction.    
AFLP is characterized by microvesicular steatosis, 
hepatic failure and encephalopathy develops in the last 
trimester of pregnancy
Fetuses with defective in mitochondrial fatty acid 
oxidation are known to be associated with AFLP
Mutation in the enzyme, long-chain 3-hydroxy acyl CoA 
dehydrogenase (LCHAD), involved in the mitochondrial 
beta-oxidation of fatty acid is highly associated with 
AFLP
In the third trimester pregnancy induces maternal 
lipolysis
In AFLP, a fetus with homozygous mutation for LCHAD 
will have his/her placenta defective to metabolize the 
long chain fatty acids resulting in the accumulation of 3-
hydroxy fatty acids
Accumulated 3-hydroxyl fatty acids and other fatty 
acids due to maternal lipolysis enter the mother’s 
circulation and affects the maternal liver resulting in the 
complication of liver disease observed in AFLP. 
Our lab previous work had demonstrated that placental 
oxidative stress and mitochondrial dysfunction were 
evident in patient’s with AFLP. 
We also reported that there was an elevated level of 
free fatty acids and hydroxy-fatty acids in the systemic 
circulation of patients with AFLP. 
Palmitoleate, a mono unsaturated fatty acids and can 
act as a lipokine
Palmitoleate has been shown to protect free fatty acid-
induced hepatocyte lipoapoptosis
Introduction Results
Conclusion
• 3-hydroxy myristic acid induces caspase- independent 
cell death in placental cells
• 3-hydroxy octanoic acid did not induce apoptosis
• 3-hydroxy myristic acid induces caspase-dependent 
hepatocyte lipoapoptosis
• Palmitoleate protects against 3-hydroxy myristic acid-
induced hepatocyte lipoapoptosis
Future Directions
Knock down LCHAD using CRISPR/ Cas 9 technology and test 3-
hydroxy fatty acid toxicity
We will test 3-hydroxy palmitic Acid toxicity in trophoblasts and 
hepatocytes. 
We will also look at the role of necroptosis with 3-hydroxy myristic acid-
induced trophoblast cell death
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Results
Department of Nutrition and Health Sciences, and Nebraska Center for the Prevention of Obesity Disease (NPOD), University of Nebraska-Lincoln 
Hypothesis
3-hydroxy fatty acids that are released from the 
placenta induces trophoblast and hepatocyte 
lipoapoptosis 
Materials and Methods
Apoptosis was determined from caspase 3/7 activity and measurement 
of percent apoptotic nuclear morphology changes using fluorescent 
microscopy 
Trophoblast cell lines (JEG-3 and JAR) or Hepatocyte (Huh7) were 
used in this study.
Cell were treated either with 20-200 µM of 3-hydroxy myristic acid (3-
HMA), or 3-hydroxy octanoic acid (3-OHC8)  for 24h in 1% BSA 
containing media
Control cells were treated with vehicle isopropanol (<1% in media)
Arachidonic acid (40, 80, 120 µM) were treated with or without 100 µM 
of 3-hydroxy myristic acid (3-HMA) for 24h in 1% BSA containing 
media
Palmitoleate (200 µM) was co-treated with 100 µM of 3-HMA for 24h in 
1% BSA containing media.
Can 3-hydroxy myristic acid induce trophoblast lipoapoptosis?
Can 3-hydroxy octanoic acid (3-OHC8) induce Trophoblast 
lipoapoptosis?
Can palmitoleate protect 3-hydroxy myristic acid-
induced hepatocyte lipoapoptosis?
Can arachidonic acid (AA) treatment aggravate 3-
hydroxy myristic acid-induced cell death?
3-HMA induce caspase-independent trophoblast cell death
3-OHC8 did not induce trophoblast apoptosis
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